Preoperative USPIO-enhanced MRI was conducted using ferumoxtran-10 (Ferrotran, SPL Medical B.V., investigational product), administered intravenously (2.6 mg/kg body weight) 24-36 h before the scan, as previously described [16] . MRI was performed on a 3-T MRI system (Magnetom Prisma, Siemens Healthcare). Butylscopolamine and glucagon were administered to minimise peristaltic motion, unless contraindicated. Patients were positioned feet first supine, with body phased array coils around the upper abdomen. The scan range was from diaphragm to aortic bifurcation. Images were acquired with repeated breath-holds of maximally 20 s on expiration. MRI sequences included T2-weighted HASTE for anatomical reference, T1-weighted VIBE DIXON for LN localisation, and fat-suppressed T2*-weighted multi gradient echo (mGRE) sequence for USPIO visualisation, mGRE images were reconstructed to a single T2*weighted computed echo time (TE) of 12 ms [17] . Table 1 describes the technical details of the MR sequences.